ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Baseimmune Ltd

Baseimmune Ltd is an active company incorporated on 30 October 2019 with the registered office located in London, Greater London. Baseimmune Ltd was registered 5 years ago.
Status
Active
Active since incorporation
Company No
12289125
Private limited company
Age
5 years
Incorporated 30 October 2019
Size
Unreported
Confirmation
Due Soon
Dated 29 October 2024 (12 months ago)
Next confirmation dated 29 October 2025
Due by 12 November 2025 (18 days remaining)
Last change occurred 11 months ago
Accounts
Submitted
For period 1 Nov31 Oct 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (11 months remaining)
Address
The London Bioscience Innovation Centre
Royal College Street
London
NW1 0NH
England
Address changed on 13 May 2022 (3 years ago)
Previous address was 71-75 Shelton Street London WC2H 9JQ England
Telephone
Unreported
Email
Unreported
People
Officers
6
Shareholders
24
Controllers (PSC)
1
Director • British • Lives in England • Born in Oct 1990
Director • British • Lives in England • Born in Jun 1991
Director • Venture Capitalist • American • Lives in England • Born in Oct 1976
Director • Brazilian • Lives in England • Born in Feb 1991
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Apperio Limited
Iq Capital Directors Nominees Ltd is a mutual person.
Active
Skin Analytics Ltd
Hussein Kanji is a mutual person.
Active
Project J Ltd
Hussein Kanji is a mutual person.
Active
BMLL Technologies Limited
Iq Capital Directors Nominees Ltd is a mutual person.
Active
Ai Build Limited
Iq Capital Directors Nominees Ltd is a mutual person.
Active
Paragraf Limited
Iq Capital Directors Nominees Ltd is a mutual person.
Active
Risilience Limited
Iq Capital Directors Nominees Ltd is a mutual person.
Active
Accelercomm Ltd
Iq Capital Directors Nominees Ltd is a mutual person.
Active
Brands
Baseimmune
Baseimmune is a discovery stage biotech company focused on antigen discovery and vaccine development.
Financials
Net Assets, Total Assets & Total Liabilities (2020–2024)
Period Ended
31 Oct 2024
For period 31 Oct31 Oct 2024
Traded for 12 months
Cash in Bank
£8.67M
Increased by £6.91M (+393%)
Turnover
Unreported
Same as previous period
Employees
17
Increased by 6 (+55%)
Total Assets
£9.69M
Increased by £7.26M (+299%)
Total Liabilities
-£66K
Decreased by £341.97K (-84%)
Net Assets
£9.62M
Increased by £7.6M (+376%)
Debt Ratio (%)
1%
Decreased by 16.12% (-96%)
Latest Activity
Ariane Karla Cruz Gomes Resigned
24 Days Ago on 30 Sep 2025
Notification of PSC Statement
1 Month Ago on 27 Aug 2025
Full Accounts Submitted
2 Months Ago on 29 Jul 2025
Accounting Period Extended
11 Months Ago on 13 Nov 2024
Confirmation Submitted
11 Months Ago on 5 Nov 2024
Full Accounts Submitted
1 Year 3 Months Ago on 17 Jul 2024
Iq Capital Directors Nominees Ltd Appointed
1 Year 9 Months Ago on 5 Jan 2024
Philip James Gordon Kemlo (PSC) Resigned
4 Years Ago on 17 Mar 2021
Ariane Karla Cruz Gomes (PSC) Resigned
4 Years Ago on 17 Mar 2021
Joshua Miles Blight (PSC) Resigned
4 Years Ago on 17 Mar 2021
Get Credit Report
Discover Baseimmune Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Statement of capital following an allotment of shares on 1 October 2025
Submitted on 1 Oct 2025
Change of share class name or designation
Submitted on 1 Oct 2025
Termination of appointment of Ariane Karla Cruz Gomes as a director on 30 September 2025
Submitted on 30 Sep 2025
Replacement filing of SH01 - 24/08/25 Statement of Capital gbp 7.8592
Submitted on 16 Sep 2025
Statement of capital following an allotment of shares on 24 August 2025
Submitted on 12 Sep 2025
Cessation of Ariane Karla Cruz Gomes as a person with significant control on 17 March 2021
Submitted on 27 Aug 2025
Cessation of Joshua Miles Blight as a person with significant control on 17 March 2021
Submitted on 27 Aug 2025
Cessation of Philip James Gordon Kemlo as a person with significant control on 17 March 2021
Submitted on 27 Aug 2025
Notification of a person with significant control statement
Submitted on 27 Aug 2025
Resolutions
Submitted on 27 Aug 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year